|
MISSION
The journal of The Experimental and Clinical
Transplantation (ECT) is the official journal of the Middle
East Society for Organ Transplantation (MESOT).
The Society was originally founded in Turkey in 1987, and was subsequently
incorporated at Bern, Switzerland, in 1988 as a non-profit, international,
scientific organization comprising 20 countries of the Middle East,
North Africa, Midmid-Asia, and neighboring nations.
The aim of the journal is to provides a medium
forum for where clinical scientists, basic scientists, ethicists,
and public health professionals to communicate ideas and advancements
advances in the field of experimental and clinical organ and tissue
transplantation, and to discuss related social and ethical issues.
The topics will be of interest to transplant surgeons, clinicians
in all major disciplines and subspecialties, basic science researchers,
and other professionals involved with sociological aspects of experimental
and clinical transplantation.
The ECT Experimental and Clinical Transplantation
is a peer-reviewed international publication that accepts manuscripts
of full-length original articles, case reports, letters to the editor,
and invited reviews. It is published in English twice yearly (a
year in June & and December).
Our editorial team is committed to producing a journal of extremely high standards. The journal is fully indexed in MEDLINE, Index Medicus and Excerpta Medica. Full-text articles are available on the Internet via PubMed or at
the Journal’s Web site, at http://www.ectrx.org.
The journal, and the objective is to have the ECT is also available
as hard-copy bound volumes, by subscription, printed on acid-free
paper.
SCOPE
The scope of the journal includes the following:
- Surgical
techniques, innovations, and novelties
- Immunobiology
and immunosuppression
- Clinical
results
- Complications
- Infection
- Malignancies
- Organ
donation
- Organ
and tissue procurement and preservation
- Sociological
and ethical issues
- Xenotransplantation
|